Sanofi taps Scribe for in vivo partnership worth more than $1.2B biobucks aimed at sickle cell and beyond
Fierce Biotech
|
July 18, 2023
X min read
Fierce Biotech
|
July 18, 2023
Share on Social
More like this
Media
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
Press
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
